S
NVAX icon

SignatureFD’s Novavax NVAX Stock Holding History

SignatureFD’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.5K Buy
7,595
+330
+5% +$2.96K ﹤0.01% 1652
2026
Q1 		$59.1K Sell
7,265
-21
-0.3% -$190 ﹤0.01% 1634
2025
Q4 		$49K Sell
7,286
-2,903
-28% -$21.9K ﹤0.01% 1659
2025
Q3 		$88.3K Buy
10,189
+450
+5% +$3.5K ﹤0.01% 1356
2025
Q2 		$61.4K Buy
9,739
+3,122
+47% +$20.7K ﹤0.01% 1478
2025
Q1 		$42.4K Buy
6,617
+581
+10% +$4.8K ﹤0.01% 1673
2024
Q4 		$48.5K Buy
6,036
+2
+0% +$19 ﹤0.01% 1605
2024
Q3 		$76.2K Buy
6,034
+354
+6% +$4.57K ﹤0.01% 1356
2024
Q2 		$71.9K Buy
5,680
+3,874
+215% +$39K ﹤0.01% 1332
2024
Q1 		$8.63K Buy
1,806
+428
+31% +$1.99K ﹤0.01% 2355
2023
Q4 		$6.61K Buy
1,378
+245
+22% +$1.5K ﹤0.01% 2423
2023
Q3 		$8.2K Buy
1,133
+15
+1% +$120 ﹤0.01% 2312
2023
Q2 		$8.31K Buy
1,118
+38
+4% +$299 ﹤0.01% 2322
2023
Q1 		$7.48K Buy
1,080
+500
+86% +$4.6K ﹤0.01% 2340
2022
Q4 		$5.96K Buy
580
+405
+231% +$7.15K ﹤0.01% 2386
2022
Q3 		$3K Sell
175
-75
-30% -$3.25K ﹤0.01% 2667
2022
Q2 		$13K Sell
250
-114
-31% -$5.91K ﹤0.01% 1997
2022
Q1 		$27K Buy
364
+13
+4% +$1.16K ﹤0.01% 1691
2021
Q4 		$50K Buy
351
+39
+13% +$6.7K ﹤0.01% 1346
2021
Q3 		$65K Buy
312
+159
+104% +$35K ﹤0.01% 1168
2021
Q2 		$32K Buy
153
+7
+5% +$1.28K ﹤0.01% 1507
2021
Q1 		$26K Buy
146
+56
+62% +$11.2K ﹤0.01% 1468
2020
Q4 		$10K Sell
90
-8
-8% -$850 ﹤0.01% 1704
2020
Q3 		$11K Buy
98
+61
+165% +$7.43K ﹤0.01% 1611
2020
Q2 		$3K Buy
+37
New +$1.42K ﹤0.01% 2003

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

SignatureFD's NVAX Position: Q2 2026 in Review

SignatureFD increased its Novavax (NVAX) stake by 4.5% in Q2 2026, buying an estimated $2.96K and bringing the position to 7,595 shares worth $71.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1652.

SignatureFD first reported a position in NVAX in Q2 2020 and has held it in 25 quarters since. The position peaked at $88.3K in Q3 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • SignatureFD held 7,595 shares of Novavax worth $71.5K as of Q2 2026.
  • SignatureFD bought 330 Novavax shares in Q2 2026, an estimated $2.96K.
  • Novavax made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1652 holding.
  • SignatureFD first reported a position in Novavax in Q2 2020 and has held it in 25 quarters since.
  • SignatureFD's Novavax position peaked at $88.3K in Q3 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.